Filing Details
- Accession Number:
- 0001209191-21-023075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-25 18:08:04
- Reporting Period:
- 2021-03-23
- Accepted Time:
- 2021-03-25 18:08:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733257 | Finch Therapeutics Group Inc. | FNCH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193038 | A Jeffery Smisek | C/O Finch Therapeutics Group, Inc. 200 Inner Belt Road, Suite 400 Somerville MA | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-23 | 894,955 | $0.00 | 894,955 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-23 | 141,928 | $0.00 | 1,036,883 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-23 | 297,178 | $0.00 | 1,334,061 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-23 | 272,245 | $0.00 | 1,606,306 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-23 | 88,235 | $17.00 | 1,694,541 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-03-23 | 894,955 | $0.00 | 894,955 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-03-23 | 141,928 | $0.00 | 141,928 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2021-03-23 | 297,178 | $0.00 | 297,178 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2021-03-23 | 272,245 | $0.00 | 272,245 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- The securities are held by Flight Partners Management LLC ("Flight Partners Capital"). The Reporting Person is the president of Flight PartnersCapital.
Billionaire Hedge Funds
